BRIEF published on 10/28/2024 at 08:05, 1 year 10 months ago Ondine Biomedical fait progresser la commercialisation de Steriwave Ondine Biomedical Technologie Steriwave Résistance Aux Antimicrobiens Innovation Dans Le Domaine De La Santé Infections Associées Aux Soins De Santé
BRIEF published on 10/28/2024 at 08:05, 1 year 10 months ago Ondine Biomedical Advances Steriwave Commercialization Antimicrobial Resistance Ondine Biomedical Steriwave Technology Healthcare-associated Infections Innovation In Healthcare
PRESS RELEASE published on 10/28/2024 at 08:00, 1 year 10 months ago Ondine Continues Commercial Growth Ondine Biomedical Inc. provides updates on the commercial roll-out of its Steriwave® nasal decolonization technology, reducing healthcare-associated infections with light-activated treatment Ondine Biomedical Inc. Nasal Decolonization Steriwave Healthcare-associated Infections Antimicrobial Treatments
BRIEF published on 10/23/2024 at 08:05, 1 year 10 months ago Ondine Biomedical Inc. lance le projet pilote Steriwave au King's College Hospital Steriwave Ondine Biomedical Innovation Dans Le Domaine De La Santé Hôpital King's College Traitement Antimicrobien
BRIEF published on 10/23/2024 at 08:05, 1 year 10 months ago Ondine Biomedical Inc. Launches Steriwave Pilot at King's College Hospital Steriwave Healthcare Innovation Ondine Biomedical Antimicrobial Treatment King's College Hospital
PRESS RELEASE published on 10/23/2024 at 08:00, 1 year 10 months ago Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave Pilot Ondine Biomedical Inc. collaborates with King's College Hospital to pilot Steriwave® light-activated antimicrobial tech for preventing HAIs. Steriwave rapidly eliminates pathogens without resistance Ondine Biomedical Inc. Steriwave Hospital-acquired Infections Antimicrobial Technology King's College Hospital
BRIEF published on 09/30/2024 at 11:10, 1 year 11 months ago Ondine Biomedical Reports Robust Growth in H1 2024 Clinical Trials Steriwave Ondine Biomedical Financial Growth Hospital Adoption
BRIEF published on 09/30/2024 at 11:10, 1 year 11 months ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Croissance Financière Steriwave Ondine Biomedical Essais Cliniques Adoption À L'hôpital
PRESS RELEASE published on 09/30/2024 at 11:05, 1 year 11 months ago Ondine Biomedical Reports Robust Growth in H1 2024 Ondine Biomedical Inc. reports unaudited operational and financial results for the first half of 2024, showing strong revenue growth and strategic partnerships Financial Performance Ondine Biomedical Inc. Strategic Partnership Clinical Trials Operational Results
BRIEF published on 09/30/2024 at 08:05, 1 year 11 months ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Résultats Financiers Ondine Biomedical Essais Cliniques Steriwave® Premier Semestre 2024
Published on 09/08/2026 at 22:15, 11 minutes ago GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Published on 09/08/2026 at 22:05, 21 minutes ago Loop Industries Appoints Jeff Geygan as Chairman of the Board
Published on 09/08/2026 at 15:40, 6 hours 46 minutes ago CANEX Increases Equity Financing to C$9 Million
Published on 09/08/2026 at 15:00, 7 hours 26 minutes ago Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 09/08/2026 at 15:00, 7 hours 26 minutes ago Norsemont to Participate at Precious Metals Summit Beaver Creek
Published on 09/08/2026 at 22:05, 21 minutes ago oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 3 hours 56 minutes ago Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 18:20, 4 hours 6 minutes ago Rönesans Named Among the World's Top 50 International Contractors for the 11th Consecutive Year
Published on 09/08/2026 at 17:45, 4 hours 41 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 4 hours 41 minutes ago Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 17:45, 4 hours 41 minutes ago Damartex / Résultats de l'exercice 2025-2026
Published on 09/08/2026 at 11:00, 11 hours 26 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 11 hours 26 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
